Scholarly Works - Conferences
Conference
Cancer Research
·
April 3, 2026
AbstractGlioblastoma remains universally lethal, with rapid recurrence and a median survival of less than two years. Current CAR T approaches in glioblastoma have been limited by a lack of uniformly expre ...
Full text
Cite
Conference
Neuro-Oncology
·
November 11, 2025
AbstractGlioblastoma (GBM) remains among the most aggressive and intractable human cancers, driven by profound intratumoral heterogeneity, dynamic cellular plasticity, and robust mechanisms of immune esca ...
Full text
Cite
Conference
Cancer Research
·
April 21, 2025
AbstractGlioblastoma (GBM) is an aggressive and heterogeneous brain tumor characterized by extensive plasticity, which contributes to resistance against conventional therapies. To address this challenge, we ...
Full text
Cite